Pyrene

Pyrene

SCHEMBL4416467

CCCCCCCCCCc1cc2cccc3ccc4cccc1c4c32.c1cc2ccc3cccc4ccc(c1)c2c34

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
TLR8 Q9NR97 7/20 0.44
KCNH2 Q12809 2/20 0.43
CYP1A2 P05177 2/20 0.43
ERBB2 P04626 1/20 0.43
FYN P06241 1/20 0.43
MAOA P21397 1/20 0.43
ACHE P22303 1/20 0.43
AHR P35869 1/20 0.43
MAPT P10636 3/20 0.42
LIPG Q9Y5X9 1/20 0.40
CYP3A4 P08684 2/20 0.39
TP53 P04637 1/20 0.39
ALOX5 P09917 1/20 0.39
TYR P14679 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
HTT P42858 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3747524 1.00 MEN1 (0.45) MEN1KMT2ATLR8KCNH2CYP1A2
SCHEMBL8225761 0.98 MEN1 (0.46) MEN1KMT2ATLR8KCNH2CYP1A2
SCHEMBL2177707 0.93 MEN1 (0.47) MEN1KMT2ATLR8CYP1A2ERBB2
SCHEMBL18076729 0.92 TLR8 (0.47) MEN1KMT2ATLR8KCNH2MAPT
SCHEMBL5749026 0.92 TLR8 (0.45) MEN1KMT2ATLR8KCNH2CYP1A2
SCHEMBL5747752 0.92 TLR8 (0.45) MEN1KMT2ATLR8KCNH2CYP1A2
SCHEMBL5748158 0.92 TLR8 (0.45) MEN1KMT2ATLR8KCNH2CYP1A2
SCHEMBL5746998 0.89 MEN1 (0.40) MEN1KMT2ATLR8KCNH2CYP1A2
SCHEMBL5748545 0.89 MEN1 (0.40) MEN1KMT2ATLR8KCNH2CYP1A2
SCHEMBL5746682 0.89 MEN1 (0.40) MEN1KMT2ATLR8KCNH2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1660638-A4 LIPOPARTICLES COMPRISING PROTEINS, METHODS OF MAKING, AND USING THE SAME INTEGRAL MOLECULAR INC (US) 2009-02-18 EP disclosed
EP-1660638-A2 LIPOPARTICLES COMPRISING PROTEINS, METHODS OF MAKING, AND USING THE SAME Integral Molecular, Inc. (US) 2006-05-31 EP disclosed
WO-2005042695-A2 LIPOPARTICLES COMPRISING PROTEINS, METHODS OF MAKING, AND USING THE SAME INTEGRAL MOLECULAR, INC. (US) 2005-05-12 WO disclosed